DCE-MRI Guided Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
DCE-MRI Guided Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer	Borderline-resectable Pancreatic Cancer	Recruiting	Not applicable	2026-02-27		NCT06173310

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Ohio State University	297

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Indiana University Medical Center	Indianapolis	United States	9
The Ohio State University	Columbus	United States	191

Clinical trials